R&D Spotlight:
Biomarkers for Translational Development Across Modalities

27 October 2027 | Online, 14:00 London | 15:00 Paris | 09:00 New York

SPONSORED BY

wuxilogo-1

Discover the latest approaches to identifying and validating translational biomarkers across therapeutic modalities. Explore how biomarker strategies can support decision-making throughout development, including the use of AI to guide biomarker identification and interpretation, and considerations for biomarkers in combination therapies and multi-modal development.

This focused online showcase brings together experts in translational medicine, biomarker development and computational approaches to examine emerging strategies for translating biomarker insights into development decisions. 

  • Strengthen Biomarker Strategies – Explore approaches to identifying and validating robust translational biomarkers to support development decisions
  • Leverage AI for Biomarker Development – Discover how AI and computational approaches can help guide biomarker identification, analysis and strategy development
  • Support Multi-Modal Development – Examine biomarker considerations across therapeutic modalities and combination approaches designed to improve immunotherapeutic response

This is your chance to see the latest tools in action, understand their real-world impact, and leave with practical takeaways to apply in your own research. 

 

VPs, Directors & Senior Managers from leading pharma & biotech companies and research institutions in the following fields and more:

 

  • Translational Medicine
  • Biomarker Development
  • Biomarker Strategy
  • Precision Medicine
  • Clinical Development
  • Translational Pharmacology
  • Computational Biology
  • Bioinformatics
  • Multi-Omics
  • Pharmacogenomics

60-Minute Agenda

14:00 - 14:15

Industry Presentation

14:15 – 14:30

Industry Presentation

14:30 - 14:45

Solution Provider Presentation

14:45 – 15:00

Panel Discussion

All speakers will join the panel discussion.
15:00

End of R&D Spotlight

Agenda

13:40 – 14:00

Industry Presentation: TACAs: Opening up the Target Space to a New Frontier

PETER SONDERMANN
Chief Executive Officer, Tacalyx
14:00 – 14:20

Industry Presentation: Innovative Strategies For Efficient NK Cell Redirection

LUKAS PEKAR
Lab Head, Merck KGaA
14:20 – 14:40

Solution Provider Presentation

For sponsorship opportunities please contact: sponsorship@oxfordglobal.com
14:40 – 15:00

See The Technology In Action + Live Q&A

15:00

End of Technology Showcase

About Technology Showcases

Our Technology Showcases are interactive, online events that bring together leading experts and innovators to share insights on the latest technology in a specific field.

This series is designed for industry professionals, scientists and researchers to stay ahead of the latest innovations. Each showcase spotlights a critical real-world success story, where leading experts share how cutting-edge technologies are transforming research and overcoming key challenges.

Each showcase features two expert talks from leaders in the field, followed by an in-depth exploration and demonstration of new technologies from our Solution Providers and a live Q&A. Gain practical insights and witness technologies in action.